Now live: Pro — the full 13F research suite for serious investorsSee pricing →
DC Funds, LP

Q3 2023 · 13F-HR

DC Funds, LPholdings as filed

Filed 2023-11-14 · accession 0001398344-23-020603

$4.9M
Reported value
3
Positions
2023-09-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
91864C107BRNSVACCITECH PLC$2.0M40.8%642,204CommonSOLE
89854M101TCRXTSCAN THERAPEUTICS INC$1.6M33.2%630,000CommonSOLE
95075A107HOWLWEREWOLF THERAPEUTICS INC$1.3M26.0%589,102CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.